{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:50:59Z","timestamp":1761519059206,"version":"build-2065373602"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.4158\/ep.3.1.47","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:28:31Z","timestamp":1365204511000},"page":"47-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Primary Hyperaldosteronism"],"prefix":"10.1016","volume":"3","author":[{"given":"Maria-Teresa","family":"Laurel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udaya M.","family":"Kabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.3.1.47_bb0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0889-8529(18)30097-5","article-title":"Primary aldosteronism: issues in diagnosis and management","volume":"23","author":"Bravo","year":"1994","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.4158\/EP.3.1.47_bb0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(94)93003-1","article-title":"Mineralocorticoid hypertension","volume":"344","author":"Gordon","year":"1994","journal-title":"Lancet."},{"key":"10.4158\/EP.3.1.47_bb0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0002-9343(83)91022-7","article-title":"The changing clinical spectrum of primary aldosteronism","volume":"74","author":"Bravo","year":"1983","journal-title":"Am J Med."},{"key":"10.4158\/EP.3.1.47_bb0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0002-9343(80)90474-X","article-title":"Normotensive primary aldosteronism","volume":"69","author":"Shiroto","year":"1980","journal-title":"Am J Med."},{"key":"10.4158\/EP.3.1.47_bb0025","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archinte.1985.00360080153023","article-title":"The renin-angiotensin system and body function","volume":"145","author":"Reid","year":"1985","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.3.1.47_bb0030","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jcem-28-7-1006","article-title":"Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism","volume":"28","author":"Newton","year":"1968","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.3.1.47_bb0035","first-page":"813","article-title":"Hypokalemia in the hypertensive patient with observations on the incidence of primary aldosteronism","volume":"116","author":"Kaplan","year":"1967","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.3.1.47_bb0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/271176a0","article-title":"Angiotensin II regulates receptor sites in the adrenal glomerulosa zone","volume":"271","author":"Hauger","year":"1978","journal-title":"Nature."},{"key":"10.4158\/EP.3.1.47_bb0045","first-page":"E181","article-title":"Atrial natriuretic peptide-induced inhibition of aldosterone secretion: a quest for mediator(s)","volume":"263","author":"Ganguly","year":"1992","journal-title":"Am J Physiol"},{"key":"10.4158\/EP.3.1.47_bb0050","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1172\/JCI111046","article-title":"Aldosterone suppression with dopamine infusion in low-renin hypertension","volume":"72","author":"Holland","year":"1983","journal-title":"J Clin Invest."},{"key":"10.4158\/EP.3.1.47_bb0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJM198107233050401","article-title":"Suppression of aldosterone by cyproheptadine in idiopathic aldosteronism","volume":"305","author":"Gross","year":"1981","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.3.1.47_bb0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0090-6980(80)90027-1","article-title":"Effects of prostaglandins on adrenal steroidogenesis in the rat","volume":"19","author":"Matsuoka","year":"1980","journal-title":"Prostaglandins."},{"key":"10.4158\/EP.3.1.47_bb0065","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1210\/endo-126-4-1860","article-title":"Endothelin enhances adrenocorticotropin-stimulated aldosterone release from cultured bovine adrenal cells","volume":"126","author":"Rosolowsky","year":"1990","journal-title":"Endocrinology."},{"key":"10.4158\/EP.3.1.47_bb0070","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.HYP.15.6.744","article-title":"Endothelin receptor subtypes and stimulation of aldosterone secretion","volume":"15","author":"Gomez-Sanchez","year":"1990","journal-title":"Hypertension."},{"key":"10.4158\/EP.3.1.47_bb0075","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/mend-5-10-1513","article-title":"The product of the CYPIIB2 gene is required for aldosterone biosynthesis in the human adrenal cortex","volume":"5","author":"Curnow","year":"1991","journal-title":"Mol Endocrinol."},{"key":"10.4158\/EP.3.1.47_bb0080","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1210\/endo-128-5-2534","article-title":"Regulation of aldosterone synthase cytochrome P-450 in rat adrenals by angiotensin II and potassium","volume":"128","author":"Shibata","year":"1991","journal-title":"Endocrinology."},{"key":"10.4158\/EP.3.1.47_bb0085","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1210\/endo.132.6.8389287","article-title":"Modulation of aldosterone synthase messenger ribonucleic acid levels by dietary sodium and potassium and by adrenocorticotropin","volume":"132","author":"Holland","year":"1993","journal-title":"Endocrinology."},{"key":"10.4158\/EP.3.1.47_bb0090","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/0303-7207(93)90175-J","article-title":"Angiotensin increases aldosterone synthase RNA levels in human NCI-H295 cells","volume":"94","author":"Holland","year":"1993","journal-title":"Mol Cell Endocrinol."},{"key":"10.4158\/EP.3.1.47_bb0095","series-title":"Biochemical Regulation of Blood Pressure","first-page":"123","article-title":"Angiotensin-converting enzyme","author":"Soffer","year":"1981"},{"issue":"Suppl 1","key":"10.4158\/EP.3.1.47_bb0100","first-page":"163","article-title":"Volume pressure relationships during development of mineralocorticoid hypertension in man","volume":"40","author":"Wenting","year":"1977","journal-title":"Circ Res."},{"key":"10.4158\/EP.3.1.47_bb0105","series-title":"Jacobson, Striker and Klahr\u2019s The Principles and Practice of Nephrology","first-page":"387","article-title":"Non-renal forms of secondary hypertension","author":"Atlas","year":"1995"},{"key":"10.4158\/EP.3.1.47_bb0110","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM197312202892502","article-title":"Hemodynamic characteristics of primary aldosteronism","volume":"289","author":"Tarazi","year":"1973","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.3.1.47_bb0115","first-page":"1860","article-title":"Corticotrophin-induced hyperaldosteronism: causing hypokalemic paralysis of thyrotoxicosis","volume":"80","author":"Kabadi","year":"1990","journal-title":"N Y State J Med."},{"key":"10.4158\/EP.3.1.47_bb0120","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJM199110243251706","article-title":"Licorice-induced hypermineralocorticoidism","volume":"325","author":"Farese","year":"1991","journal-title":"N Engl J Med."},{"issue":"2","key":"10.4158\/EP.3.1.47_bb0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0889-8529(18)30102-6","article-title":"Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess","volume":"23","author":"Walker","year":"1994","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.4158\/EP.3.1.47_bb0130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1056\/NEJM199401203300305","article-title":"Liddle\u2019s syndrome revisited: a disorder of sodium reabsorption in the distal tubule","volume":"330","author":"Botero-Velez","year":"1994","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.3.1.47_bb0135","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/0003-4819-116-10-813","article-title":"Glucocorticoid-remediable aldosteronism in a larger kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype","volume":"116","author":"Rich","year":"1992","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.3.1.47_bb0140","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/jcem-58-5-783","article-title":"Primary adrenal hyperplasia: a new subset of primary hyperaldosteronism","volume":"58","author":"Banks","year":"1984","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.3.1.47_bb0145","first-page":"36","article-title":"New types of primary aldosteronism [abstract]","volume":"123A","author":"Irony","year":"1988","journal-title":"Clin Res."},{"key":"10.4158\/EP.3.1.47_bb0150","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jcem-23-4-358","article-title":"Aldosteronism and precocious puberty due to an ovarian androblastoma (Sertoli cell tumor)","volume":"23","author":"Ehrlich","year":"1963","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.3.1.47_bb0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-5347(17)62839-8","article-title":"Heterotopic adrenocortical adenoma producing primary aldosteronism","volume":"98","author":"Flanagan","year":"1967","journal-title":"J Urol."},{"key":"10.4158\/EP.3.1.47_bb0160","doi-asserted-by":"crossref","first-page":"877","DOI":"10.7326\/0003-4819-121-11-199412010-00010","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"121","author":"Blumenfeld","year":"1994","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.3.1.47_bb0165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0025-6196(12)62114-4","article-title":"Primary aldosteronism: diagnosis and treatment","volume":"65","author":"Young","year":"1990","journal-title":"Mayo Clin Proc."},{"issue":"2","key":"10.4158\/EP.3.1.47_bb0170","first-page":"116","article-title":"Primary aldosteronism","volume":"15","author":"Holland","year":"1995","journal-title":"Semin Nephrol."},{"key":"10.4158\/EP.3.1.47_bb0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/pgmj.71.839.561","article-title":"Renal calculi in primary hyperaldosteronism","volume":"71","author":"Kabadi","year":"1995","journal-title":"Postgrad Med J."},{"key":"10.4158\/EP.3.1.47_bb0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0002-9343(85)90328-6","article-title":"Calcium metabolism and parathyroid function in primary aldosteronism","volume":"78","author":"Resnick","year":"1985","journal-title":"Am J Med."},{"key":"10.4158\/EP.3.1.47_bb0185","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.1993.00410180075008","article-title":"The diagnosis of primary aldosteronism and separation of two major subtypes","volume":"153","author":"Weinberger","year":"1993","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.3.1.47_bb0190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.HYP.17.2.251","article-title":"Spectrum of mineralocorticoid hypertension","volume":"17","author":"Biglieri","year":"1991","journal-title":"Hypertension."},{"key":"10.4158\/EP.3.1.47_bb0195","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.HYP.6.5.717","article-title":"Further evaluation of saline infusion for the diagnosis of primary aldosteronism","volume":"6","author":"Holland","year":"1984","journal-title":"Hypertension."},{"key":"10.4158\/EP.3.1.47_bb0200","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2265.1992.tb02252.x","article-title":"Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism","volume":"36","author":"Hambling","year":"1992","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP.3.1.47_bb0205","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0022-5347(17)35781-6","article-title":"Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia","volume":"150","author":"Gleason","year":"1993","journal-title":"J Urol."},{"key":"10.4158\/EP.3.1.47_bb0210","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2214\/ajr.158.3.1738993","article-title":"Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies","volume":"158","author":"Radin","year":"1992","journal-title":"Am J Roentgenol."},{"key":"10.4158\/EP.3.1.47_bb0215","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/radiology.184.3.1509049","article-title":"Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT","volume":"184","author":"Doppman","year":"1992","journal-title":"Radiology."},{"key":"10.4158\/EP.3.1.47_bb0220","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0002-9343(84)90521-7","article-title":"Scintigraphic localization of adrenal lesions in primary aldosteronism","volume":"77","author":"Gross","year":"1984","journal-title":"Am J Med."},{"key":"10.4158\/EP.3.1.47_bb0225","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1056\/NEJM198407123110205","article-title":"Idiopathic hyperaldosteronism: a possible role for aldsoterone-stimulating factor","volume":"311","author":"Carey","year":"1984","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.3.1.47_bb0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1210\/jcem-60-1-67","article-title":"The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycortisone levels","volume":"60","author":"Kem","year":"1985","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.3.1.47_bb0235","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/clpt.1982.9","article-title":"Amiloride in primary hyperaldosteronism","volume":"31","author":"Griffing","year":"1982","journal-title":"Clin Pharmacol Ther."},{"key":"10.4158\/EP.3.1.47_bb0240","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/jcem-60-5-896","article-title":"Therapeutic effect of calcium channel blockade in primary aldosteronism","volume":"60","author":"Nadler","year":"1985","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.3.1.47_bb0245","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ki.1984.215","article-title":"Primary aldosteronism [clinical conference]","volume":"26","author":"Melby","year":"1984","journal-title":"Kidney Int."},{"issue":"Suppl I","key":"10.4158\/EP.3.1.47_bb0250","first-page":"1207","article-title":"Clinical implications of primary aldosteronism with resistant hypertension","volume":"11","author":"Bravo","year":"1988","journal-title":"Hypertension."},{"issue":"2","key":"10.4158\/EP.3.1.47_bb0255","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0889-8529(18)30425-0","article-title":"Primary aldosteronism","volume":"17","author":"Young","year":"1988","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.4158\/EP.3.1.47_bb0260","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.HYP.8.1.76","article-title":"New insights into the medical management of primary aldosteronism","volume":"8","author":"Hsueh","year":"1986","journal-title":"Hypertension."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20429398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20429398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/WMUPPBXYH370LD7E.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:17:07Z","timestamp":1761517027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20429398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["S1530891X20429398"],"URL":"https:\/\/doi.org\/10.4158\/ep.3.1.47","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[1997,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Hyperaldosteronism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.3.1.47","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}